|
Genome-wide cell-free DNA (cfDNA) methylation signatures and effect on tissue of origin (TOO) performance. |
|
|
Research Funding - Eisai (Inst); GRAIL (Inst); Janssen Diagnostics (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro (Inst) |
Travel, Accommodations, Expenses - Agena Bioscience; Celgene; Cynvenio Biosystems; GRAIL; Menarini Silicon Biosystems; Merck; Pfizer |
|
|
|
Stock and Other Ownership Interests - GRAIL; Illumina |
Patents, Royalties, Other Intellectual Property - GRAIL (Inst) |
|
|
|
Stock and Other Ownership Interests - GRAIL |
Patents, Royalties, Other Intellectual Property - GRAIL (Inst) |
|
|
|
Stock and Other Ownership Interests - GRAIL |
Patents, Royalties, Other Intellectual Property - GRAIL (Inst) |
|
|
|
Stock and Other Ownership Interests - GRAIL |
Patents, Royalties, Other Intellectual Property - GRAIL (Inst) |
|
|
|
Stock and Other Ownership Interests - GRAIL |
Patents, Royalties, Other Intellectual Property - GRAIL (Inst) |
|
|
|
Stock and Other Ownership Interests - GRAIL; Illumina |
Patents, Royalties, Other Intellectual Property - GRAIL (Inst) |
|
|
|
Stock and Other Ownership Interests - GRAIL |
Patents, Royalties, Other Intellectual Property - GRAIL (Inst) |
|
|
|
Stock and Other Ownership Interests - GRAIL |
Patents, Royalties, Other Intellectual Property - GRAIL (Inst) |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
|
Stock and Other Ownership Interests - GRAIL |
Patents, Royalties, Other Intellectual Property - GRAIL (Inst) |
|
|
|
Stock and Other Ownership Interests - GRAIL; Illumina |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bio-Rad; Chugai Pharma; Guardant Health; Sysmex |
Consulting or Advisory Role - AstraZeneca; DropWorks; GRAIL; Ignyta; Inivata; LOXO; Takeda |
Patents, Royalties, Other Intellectual Property - DFCI has a patent pending titled "Non-invasive blood-based monitoring of genomic alterations in cancer", on which I am a co-author. (Inst) |
|
|
Consulting or Advisory Role - GenomeDx; Genomic Health |
Speakers' Bureau - Genomic Health |
|
|
Leadership - TriStar Centennial Medical Center |
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Evelo Therapeutics (Inst); Foundation Medicine (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Illumina (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Precision Oncology (Inst); Takeda (Inst); TRM Oncology (Inst) |
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Aeglea Biotherapeutics (Inst); Amgen (Inst); ARMO BioSciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Foundation Medicine (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); GRAIL (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Nektar (Inst); Neon Therapeutics (Inst); Novartis (Inst); Oncogenex (Inst); Pfizer (Inst); Takeda (Inst); Tesaro (Inst); Transgene (Inst); University of Texas Southwestern Medical Center - Simmons Cancer Center (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; Genzyme; Intuitive Surgical; Lilly; Merck; Pfizer; Purdue Pharma; Spectrum Pharmaceuticals; Sysmex |
|
|
Employment - GRAIL; Myriad Genetics |
Stock and Other Ownership Interests - GRAIL; Myriad Genetics |
|
|
|
Stock and Other Ownership Interests - GRAIL |
|
|
Employment - McKesson; Texas Oncology (I) |
Leadership - Nemucore Medical Innovations; Next Oncology; US Oncology |
Stock and Other Ownership Interests - Bristol-Myers Squibb; McKesson; Merck; Nemucore Medical Innovations |
Honoraria - Bristol-Myers Squibb |
Consulting or Advisory Role - Grail |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Grail; McKesson |